Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2).

J Hematol Oncol · 2022 · PMC9261106 · PMID 35794616

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients with CR had a sharper drop in sBCMA level from baseline than patients who did not achieve CR, but this did not reach statistical significance (Additional file 1 : Table S4).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.